Novel nonsecosteroidal vitamin D3 carboxylic acid analogs for osteoporosis, and SAR analysis

Bioorg Med Chem. 2011 Aug 15;19(16):4721-9. doi: 10.1016/j.bmc.2011.07.001. Epub 2011 Jul 8.

Abstract

Novel vitamin D(3) analogs with carboxylic acid were explored, focusing on a nonsecosteroidal analog, LG190178, with a bisphenyl skeleton. From X-ray analysis of these analogs with vitamin D receptor (VDR), the carboxyl groups had very unique hydrogen bonding interactions in VDR and mimicked 1α-hydroxy group and/or 3β-hydroxy group of 1α,25-dihydroxyvitamin D(3). A highly potent analog, 6a, with good in vitro activity and pharmacokinetic profiles was identified from an SAR study. Compound 6a showed significant prevention of bone loss in a rat osteoporosis model by oral administration.

MeSH terms

  • Animals
  • Bone Density / drug effects
  • Bone Density Conservation Agents / chemical synthesis*
  • Bone Density Conservation Agents / chemistry
  • Bone Density Conservation Agents / pharmacology
  • Calcitriol / analogs & derivatives
  • Calcitriol / chemistry
  • Calcitriol / pharmacology
  • Calcium / blood
  • Cell Line
  • Cholecalciferol / analogs & derivatives*
  • Cholecalciferol / pharmacology
  • Cholecalciferol / therapeutic use
  • Drug Evaluation, Preclinical
  • Female
  • Humans
  • Mice
  • Osteocalcin / analysis
  • Osteocalcin / physiology
  • Osteoporosis / drug therapy*
  • Osteoporosis / physiopathology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Calcitriol / agonists
  • Receptors, Calcitriol / drug effects
  • Receptors, Calcitriol / genetics
  • Steroids / chemistry
  • Structure-Activity Relationship

Substances

  • Bone Density Conservation Agents
  • Receptors, Calcitriol
  • Steroids
  • Osteocalcin
  • Cholecalciferol
  • Calcitriol
  • Calcium